Summary.-A microradioimmunoassay technique is described for detecting carcinoembryonic antigen (CEA) in whole serum. It differs from previous methods in being performed on 0-025 ml of whole serum instead of 5 ml of serum extracted with perchloric acid. The present assay was sufficiently sensitive to detect 85 % of carcinomata, localized to the colon, but positive results occurred also with certain non-gastrointestinal cancers, chiefly lung and breast, and certain non-malignant diseases. Many of the latter sera, with the general exception of alcoholic cirrhosis and pancreatitis, gave negative results after extraction with perchloric acid. It is suggested that a direct assay for CEA in whole serum may permit testing of large numbers of sera by laboratories with facilities for radioimmunoassays.
CARCINOEMBRYONIC antigen (CEA) is an antigen present in human foetal digestive tissues and in cancer of these tissues in adult life (Gold and Freedman, 1 965a, 1 965b; Krupey, Gold and Freedman, 1968) . It may also be found in the serum of patients with gastrointestinal cancer. Detection of CEA in serum therefore promises to be of aid in the diagnosis of these cancers. A radioimmunoassay technique for CEA has been developed (Thomson et al., 1969; Moore et al., 1971;  LoGerfo, Krupey and Hansen, 1971) which required as an initial step extraction of the antigen from serum with perchloric acid. In this paper we describe a radioimmunoassay for detection of CEA in small samples of whole serum.
MATERIALS AND METHODS
Sera were obtained from 51 blood donors and from 326 patients selected to include those with various neoplastic and nonneoplastic diseases.
Purified CEA and a goat antiserum to CEA were generously provided by Dr P. Gold, Montreal. Samples (20 jug) of CEA were labelled with 1251 using chloramine T as oxidant (Hunter and Greenwood, 1962) ; the specific activity of various preparations was 22-50 uCi/,ug. The labelled antigen was diluted in 0 01 mol/l tris buffer, pH (Thomson et al., 1969) , and antiserum to goat gamma globulin. Inhibition by test serum of precipitation of 125I CEA with antiserum to CEA was compared with the degree of inhibition given by unlabelled purified CEA, and the concentration of CEA in the test serum accordingly determined; levels of lOng/ml were detectable.
In the alternative procedure for precipitation, using rabbit antiserum to goat gamma globulin (Hoechst Australia, Limited), test human serum was held with antiserum to CEA at 37TC for 2 hours and overnight at 4°C before the addition of 125I CEA. After a further period of 2 hours at 37TC and overnight at 4°C, 100 p,l of a 1: 20 dilution of rabbit antiserum to goat gamma globulin was added to each tube; tubes were held at 37TC for 2 hours and overnight at 4°C and centrifuged, and supernates were counted as described above, using the same sets of controls. Aspects relating to conditions for antigen-antibody interaction and precipitation of immune complexes will be reported in detail elsewhere. Levels of CEA in serum of 5 ng/ml were detectable.
A third series of assays was carried out to compare results on whole serum with those obtained on sera extracted with perchloric acid. 0 1 ml of 4 mol/l perchloric acid was added to 0 4 ml of serum whilst the serum was agitated on a vortex mixer; the tubes were centrifuged at 4000 g for 10 minutes and the supernate dialysed against multiple changes of 0-01 molfl phosphate buffered saline, pH 7 3, for 2 days; 25 pi samples of the extract were assayed for CEA, as described, with precipitation of immune complexes by ammonium sulphate. Precipitation was facilitated by adding a 5 x 10-1 dilution of normal goat serum to the antiserum to CEA. Control tubes contained perchloric acid extracts of pooled normal human serum. A standard inhibition curve was obtained by including with each assay perchloric acid extracts of pooled normal human serum to which had been added, before extraction, doubling dilutions of unlabelled CEA. When levels of CEA were low, tests were occasionally repeated on supernates concentrated by lyophilization. Levels of CEA in serum of 3 ng per ml were detectable.
RESULTS
The results of assays for CEA are shown in Tables I and II . The inhibition of the reaction between 125I CEA-anti CEA produced by the test sera are expressed as ng of CEA per ml of serum relative to the purified CEA standard. The results of assays for CEA in whole serum using precipitation by rabbit antigoat serum (Table II) were generally similar to those using ammonium sulphate precipitation (Table I) . However, more sera gave detectable levels of CEA, particularly sera from patients with (Thomson et al., 1969) . More recent studies, however, have shown that CEA can also be detected in the sera of patients with non-intestinal cancer, particularly of lung and breast, in certain non-neoplastic diseases, particularly of gastrointestinal or pulmonary origin, and in uraemia (Moore et al., 1971; LoGerfo et al., 1971) . Our present results are in accord with these observations, in showing that CEA was detected in association with cancer of the colon, stomach, pancreas, breast and lung, and in lower concentration in some non-malignant diseases. The cases of cancer of the colon were " staged " only to the degree of differentiating " local " and " disseminated " cancer; " local " refers to cancers restricted to the wall of the bowel (Duke's Class 1) and " disseminated " to cancers extending beyond the wall of the bowel (Duke's Class 2 and 3, and distant metastases). Other cancers were not " staged ". We note that sera from 20 of 23 " local " colon cancers were positive, as were all of 21 " disseminated " cancers, using antiglobulin precipitation of complexes (Table II) .
In previous studies (Thomson et al., 1969; Moore et al., 1971; LoGerfo et al., 1971) , CEA was detected in serum only after extraction with perchloric acid, dialysis and usually lyophilization, using approximately 5 ml of patient serum as opposed to 0-025 ml of whole serum in our modified microassay. However, it is first relevant to compare our results on sera extracted with perchloric acid with those cited in previous reports. The present microassay, using 25 1dl of extracted serum, was sufficiently sensitive that 3 ng/ml of CEA could be detected. With extracted sera, we found that most cases of disseminated carcinoma of the colon, other intestinal cancers and cancer of the lung and breast gave values over 3 ng/ml, although sera from 6 of 17 patients with cancers known to be localized to the colon had no detectable levels.
The present studies were designed to develop a microassay technique which would detect CEA in small volumes of whole serum. This was achieved in assays in which the complexes were precipitated by rabbit antiserum to goat gamma globulin. This proved better than precipitation of complexes by ammonium sulphate; however, we note that the lowest detectable level of CEA was 10 ng/ml using ammonium sulphate. Taking each of our methods into consideration, the highest incidence of positive assays for CEA with normal human sera was 10%0 (5/51), with levels between 3-1Ong/ml, all other sera having values less than 3 ng/ml. It may be that all human sera contain some CEA, and considerably more work will be required in order to derive a " normal range ".
Most of the sera from patients without cancer which gave levels of CEA over 5 ng/ml in direct tests on whole serum were re-assayed after extraction with perchloric acid in order to reassess these apparently " false positive " results. The assay remained positive with many sera of patients with alcoholic cirrhosis of the liver and pancreatitis; it is assumed that such sera do in fact contain CEA. Of the 4 positive sera from patients with miscellaneous diseases, extraction resulted in a reduction in the level of CEA, from greater than 20 ng/ml to less than 15 ng/ml. Negative results in assays for CEA using whole serum from patients with known cancer of the colon remained negative after extraction. Hence, we conclude that although a satisfactorily sensitive microimmunoassay technique for detecting CEA in whole serum was attained, " false positive " results occur in some conditions other than cancer, so that positive sera should be re-assayed after extraction with perch]oric acid; conversely, negative results may occur in small cancers localized in the colon. To validate further this conclusion, a larger series of sera from patients with cancers and other diseases is being processed by all 3 assay methods.
The assays on whole serum reported here were carried out by a micro-method requiring only 25 ,ul of serum. Such assays can therefore be performed on fresh or stored sera drawn for other purposes, and many determinations can be made on the one sample. Since this assay merely requires the addition of reagents, centrifugation and sampling of supernates, it should be readily adaptable to automated techniques. Although further studies on specificity of the assay are required and additional modifications may be needed to reduce the frequency of " false positive " results in relation to cancer, the assay for CEA in whole serum appears applicable to the testing of large numbers of sera by routine laboratories with facilities for radioimmunoassays.
